ROLE OF ARGON LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY (CSCR) IN TERMS OF MEAN CHANGE IN BEST CORRECTED VISUAL ACUITY
DOI:
https://doi.org/10.71000/ysyrs689Keywords:
best corrected visual acuity, argon laser photocoagulation, , chronic disease, laser therapy, optical coherence tomography, retinal pigment epithelium, serous retinal detachment.Abstract
Background: Central serous chorioretinopathy (CSCR) is a common retinal disorder characterized by serous detachment of the neurosensory retina due to dysfunction of the retinal pigment epithelium and choroid. Chronic CSCR, defined by persistent subretinal fluid for more than four months, may result in permanent visual impairment if left untreated. Argon laser photocoagulation has been employed to promote subretinal fluid absorption by sealing the leakage point and enhancing RPE function. However, risks such as choroidal neovascularization and retinal scarring warrant careful evaluation of its efficacy.
Objective: To determine the mean change in best corrected visual acuity (BCVA) following argon laser application in adults diagnosed with chronic CSCR.
Methods: This descriptive case series was conducted at Eye Unit I, Department of Ophthalmology, Allied Hospital Faisalabad, affiliated with Faisalabad Medical University, from March 1 to August 31, 2021. A total of 35 patients, aged 16–70 years, with chronic CSCR confirmed on OCT and FFA, were selected via non-probability consecutive sampling. Exclusion criteria included repeat laser therapy, choroidal neovascularization, inflammatory/neoplastic choroidal disease, or congenital optic disc anomalies. Baseline BCVA was assessed using Snellen’s chart. Argon green laser (514 nm) was applied to leakage points at least 500 µm away from the fovea by a senior consultant. Patients were followed up at 4, 8, and 12 weeks for BCVA reassessment.
Results: Mean BCVA improved from 0.35 ± 0.04 at baseline to 0.68 ± 0.05 at 4 weeks, 0.89 ± 0.02 at 8 weeks, and 0.98 ± 0.03 at 12 weeks. The overall mean change in BCVA was 0.64 ± 0.05.
Conclusion: Argon laser photocoagulation significantly improved visual acuity in chronic CSCR patients and may be considered a safe, effective treatment where focal leakage is present.
References
Toto L, Ares I, Quarta A, Viggiano P, Ruggeri M, Formenti F, et al. Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2025;263(2):405-14.
Kim LA, Maguire MG, Weng CY, Smith JR, Jain N, Flaxel CJ, et al. Therapies for Central Serous Chorioretinopathy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025;132(3):343-53.
Gao S, Ge G, Zhang Y, Zhang M. Subthreshold Micropulse Laser Versus Oral Spironolactone in Chronic Central Serous Chorioretinopathy: A Quasi-Randomized Controlled Trial. Transl Vis Sci Technol. 2024;13(8):19.
Matsumoto H, Hoshino J, Nakamura K, Ohyama Y, Morimoto M, Mukai R, et al. Quadrant laser photocoagulation trial to ameliorate choroidal congestion in central serous chorioretinopathy. Jpn J Ophthalmol. 2023;67(2):156-63.
Kathare R, Gandhi P, Prabhu V, Bavaskar S, Chhablani J, Venkatesh R. Posterior staphyloma-induced serous maculopathy: Evolution and successful treatment with subthreshold micro pulse Laser. Eur J Ophthalmol. 2024;34(6):Np48-np53.
Fossataro F, Fossataro C, Abraham N, Fouad Y, Mrejen S, Tan ACS, et al. Pathogenesis of Central Serous Chorioretinopathy and the Link Between Choroidal Hyperpermeability and Retinal Pigment Epithelium Pump Reversal. Am J Ophthalmol. 2024;266:206-17.
Maltsev DS, Kulikov AN, Vasiliev AS, Kazak AA, Kalinicheva YA, Chhablani J. Microsecond Pulsing Laser for Choroidal Neovascularization Associated with Central Serous Chorioretinopathy. Curr Eye Res. 2025;50(3):304-13.
Yusuf IH, Henein C, Sivaprasad S. Infographic: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Eye (Lond). 2024;38(Suppl 2):35-6.
Son KY, Lim SG, Hwang S, Choi J, Kim SJ, Kang SW. Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes. Br J Ophthalmol. 2024;109(1):89-97.
Iovino C, Iodice CM, Damiano L, Pisani D, Testa F, Rossi S, et al. Fluorescein angiography patterns and subretinal hyperreflective material predict subthreshold micropulse laser response in chronic central serous chorioretinopathy. BMC Ophthalmol. 2024;24(1):478.
Fasler K, Turgut F, Gunzinger JM, Sommer C, Muth DR, Kinzl S, et al. Efficacy of Subthreshold Micropulse Laser for Central Serous Chorioretinopathy. Klin Monbl Augenheilkd. 2024;241(4):489-95.
Yao J, Yang K, He J, Ran L. Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: a case report. BMC Ophthalmol. 2025;25(1):75.
Sun Z, Huang Y, Nie C, Wang Z, Pei J, Lin B, et al. Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy. Eye (Lond). 2020;34(9):1592-9.
Maltsev DS, Kulikov AN, Vasiliev AS, Kazak AA, Kalinicheva YA, Chhablani J. Direct navigated focal laser photocoagulation of choroidal neovascularization in central serous chorioretinopathy. Lasers Med Sci. 2025;40(1):173.
Brelen ME, Ho M, Li S, Ng DSC, Yip YWY, Lee WS, et al. Comparing Half-Dose Photodynamic Therapy with Subthreshold Micropulse Laser for the Treatment of Central Serous Chorioretinopathy. Ophthalmol Retina. 2024;8(5):490-8.
Sun Y, Zhao M, Miao H, Qi H. Comparative efficacy of subthreshold micropulse laser versus conventional laser therapy in central serous chorioretinopathy. Lasers Med Sci. 2025;40(1):225.
Karapapak M, Özal E, Ermiş S, Özal SA. Comparative efficacy of subthreshold micropulse laser therapy for chronic central serous chorioretinopathy: Navigated vs. non-navigated approach. J Fr Ophtalmol. 2025;48(5):104483.
Wang H, Zhao D, Ran L, Li S, Long Y, Wang M, et al. A clinical study on the therapeutic effects of 577 nm micropulse laser photocoagulation treatment in early-stage CSCR patients. BMC Ophthalmol. 2024;24(1):495.
Volodin PL, Ivanova EV. Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2020;51(9):512-20.
Gandhi P, Prabhu V, Hande P, Kathare R, Choudhary A, Chhablani J, et al. Choroidal and retinal exudative changes following extensive endolaser pan retinal photocoagulation. BMC Ophthalmol. 2024;24(1):357.
Ochinciuc R, Munteanu M, Baltă G, Baltă F. Central serous chorioretinopathy in pregnancy. Rom J Ophthalmol. 2022;66(4):382-5.
Nguyen NV, Khan F, Emig M, Yeh S. Management of Atypical Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease. J Vitreoretin Dis. 2023 May 1;7(3):249–53.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mubashir Nasir, Muhammad Ahsen, Syed Jahanzaib Naqvi, Sabahat Aslam, Fatima Rauf (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.